ATE400259T1 - Verwendung von colipase-lipase-hemmern bei der herstellung einer pharmazeutischen zusammensetzung zur prävention von adipositas - Google Patents

Verwendung von colipase-lipase-hemmern bei der herstellung einer pharmazeutischen zusammensetzung zur prävention von adipositas

Info

Publication number
ATE400259T1
ATE400259T1 AT04775323T AT04775323T ATE400259T1 AT E400259 T1 ATE400259 T1 AT E400259T1 AT 04775323 T AT04775323 T AT 04775323T AT 04775323 T AT04775323 T AT 04775323T AT E400259 T1 ATE400259 T1 AT E400259T1
Authority
AT
Austria
Prior art keywords
obesity
colipase
prevention
preparation
lipase inhibitors
Prior art date
Application number
AT04775323T
Other languages
English (en)
Inventor
Charlotte Erlanson-Albertsson
Original Assignee
Forskarpatent I Syd Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskarpatent I Syd Ab filed Critical Forskarpatent I Syd Ab
Application granted granted Critical
Publication of ATE400259T1 publication Critical patent/ATE400259T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04775323T 2003-08-21 2004-08-19 Verwendung von colipase-lipase-hemmern bei der herstellung einer pharmazeutischen zusammensetzung zur prävention von adipositas ATE400259T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302253A SE0302253D0 (sv) 2003-08-21 2003-08-21 Lipase-colipase inhibitor

Publications (1)

Publication Number Publication Date
ATE400259T1 true ATE400259T1 (de) 2008-07-15

Family

ID=28450267

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04775323T ATE400259T1 (de) 2003-08-21 2004-08-19 Verwendung von colipase-lipase-hemmern bei der herstellung einer pharmazeutischen zusammensetzung zur prävention von adipositas

Country Status (10)

Country Link
US (2) US7425577B2 (de)
EP (1) EP1660062B1 (de)
JP (1) JP2007502811A (de)
AT (1) ATE400259T1 (de)
AU (1) AU2004266561A1 (de)
CA (1) CA2536422A1 (de)
DE (1) DE602004014941D1 (de)
DK (1) DK1660062T3 (de)
SE (1) SE0302253D0 (de)
WO (1) WO2005018625A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040197321A1 (en) * 2002-03-19 2004-10-07 Tibor Sipos Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
US20100021505A1 (en) * 2008-07-28 2010-01-28 Tibor Sipos Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4816161B1 (de) * 1970-06-30 1973-05-19
US3896158A (en) * 1972-04-05 1975-07-22 Minnesota Mining & Mfg N,n-dialkylalkanolamines
GB1471431A (en) * 1974-04-30 1977-04-27 Science Union & Cie Alkanolamine derivatives processes for their preparation and pharmaceutical compositions containing them
US4062764A (en) * 1976-07-28 1977-12-13 Nalco Chemical Company Method for neutralizing acidic components in petroleum refining units using an alkoxyalkylamine
US4490455A (en) * 1982-12-20 1984-12-25 Xerox Corporation Amine acid salt charge enhancing toner additives
US4588843A (en) * 1984-04-26 1986-05-13 Ethyl Corporation Synthesis of (alkoxyalkyl) amines
DK583687A (da) * 1986-11-20 1988-05-21 Draco Ab Middel til regulering af appetit eller sovemiddel
JPH06172310A (ja) * 1990-03-20 1994-06-21 Banyu Pharmaceut Co Ltd 抗高脂血症作用を有する置換アミン誘導体
FR2758143B1 (fr) * 1997-01-07 1999-02-19 Laphal Laboratoire De Pharmaco Inhibiteurs specifiques de la lipase pancreatique et leurs applications
HUP0100890A3 (en) * 1998-01-09 2001-12-28 Genzyme Corp Cambridge Fat-binding polymers
US6521266B1 (en) * 1999-09-23 2003-02-18 Morris A. Mann Composition for growth hormone production and release, appetite suppression, and methods related thereto

Also Published As

Publication number Publication date
DE602004014941D1 (de) 2008-08-21
US20080227865A1 (en) 2008-09-18
DK1660062T3 (da) 2008-11-10
US20060199869A1 (en) 2006-09-07
EP1660062B1 (de) 2008-07-09
WO2005018625A1 (en) 2005-03-03
EP1660062A1 (de) 2006-05-31
JP2007502811A (ja) 2007-02-15
CA2536422A1 (en) 2005-03-03
AU2004266561A1 (en) 2005-03-03
US7425577B2 (en) 2008-09-16
SE0302253D0 (sv) 2003-08-21

Similar Documents

Publication Publication Date Title
EA200501805A1 (ru) Фармацевтическая композиция, содержащая ингибитор фермента дипептидилпептидазы
BRPI0410630A (pt) antagonista de nk1
DE60117605D1 (de) Thiazolyl-inhibitoren von tyrosinkinasen der tec-familie
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
ATE451369T1 (de) Piperidinopyrimidindipeptidylpeptidaseinhibitor n zur behandlung von diabetes
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
SE0301882D0 (sv) New use I
MY148690A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
MX2009008439A (es) Nuevos inhibidores de la replicacion del virus de hepatitis c.
DE69936102D1 (de) Verwendung von tnf-alpha inhibitoren zur behandlung von nervenwurzelschäden
SE0301886D0 (sv) New use V
DE602005023753D1 (de) Aminopiperidine als dipeptidylpeptidase-iv-inhibitoren zur behandlung oder prävention von diabetes
BR0307833A (pt) Sìntese controlada de ziprasidona e suas composições
EA200600689A1 (ru) Замещённые бензазолы и их применение в качестве ингибиторов raf киназы
UA100840C2 (ru) Композиция для лечения вирусного гепатита
DE60323765D1 (de) Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
BR0304648A (pt) Combinação de inibidores de ciclooxigenase-2 e talidomida para o tratamento de neoplasia
TW200514772A (en) Novel tetrahydropyridine derivatives
DE602004011255D1 (de) Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
ATE349448T1 (de) Pyrazol-3,4-d-pyrimidinderivate und ihre verwendung bei der behandlung von h.pylori- infektionen
BRPI0416030A (pt) pirido-7-pirimidin-7-onas substituìdas com hidroxialquila

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties